MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 22.090
- +0.780+3.66%
Close Dec 20 16:00 ET
- 22.020
- -0.070-0.32%
Post 20:01 ET
25.03BMarket Cap-25.99P/E (TTM)
22.170High21.110Low13.25MVolume21.210Open21.310Pre Close290.98MTurnover1.18%Turnover RatioLossP/E (Static)1.13BShares22.17052wk High4.13P/B24.88BFloat Cap10.34052wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM4.97%Amplitude3.107Historical Low21.955Avg Price1Lot Size
About Teva Pharmaceutical Industries Company
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Company Profile
SymbolTEVA
Company NameTeva Pharmaceutical Industries
Listing DateMay 30, 2012
Founded1901
CEOMr. Richard D. Francis
MarketNYSE
Employees37851
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address124 Dvora HaNevi'a Street
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6944020
Phone972-3-914-8213
Websitehttp://www.tevapharm.com
Company Executives
- Name
- Position
- Salary
- Richard D. Francis
- Director, President and Chief Executive Officer
- 25.71M
- Eli Kalif
- Executive Vice President and Chief Financial Officer
- 4.94M
- David R. McAvoy
- Executive Vice President and Chief Legal Officer
- --
- Eric A Hughes
- Executive Vice President, Global R&D and Chief Medical Officer
- --
- Amir Weiss
- Senior Vice President and Chief Accounting Officer
- --
- Christine Fox
- Executive Vice President, U.S. Commercial
- --
- Angus Grant
- Executive Vice President, Business Development
- --
- Matthew Shields
- Executive Vice President, Global Operations
- --
- Richard Daniell
- Executive Vice President, European Commercial
- 5.16M
- Mark Sabag
- Executive Vice President, International Markets Commercial
- 3.73M
- Dr. Sol J. Barer,PhD
- Chairman of the Board
- 539.99K
- Janet S. Vergis
- Independent Director
- 325.46K
- Amir Elstein
- Independent Director
- 340.00K
- Professor Varda Shalev
- Independent Director
- 176.66K
- Roberto A. Mignone
- Independent Director
- 340.00K
- Dr. Tal Zaks, M.D.,PhD
- Independent Director
- 330.00K
- Chen Lichtenstein
- Independent Director
- --
- Gerald M. Lieberman
- Independent Director
- 355.00K
- Professor Ronit Satchi-Fainaro
- Independent Director
- 315.25K
- Rosemary A. Crane, M.B.A.
- Independent Director
- 330.00K
- Dr. Perry D. Nisen
- Independent Director
- 327.87K
- Vikki L. Conway
- Acting Head of Global Human Resources
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
